Ji Zhang

Ji Zhang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

9 January 2026 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
WCWu Chen
Wu Chen
LYLing Yang
Ling Yang
JZJi Zhang
Ji Zhang
YYYe Yuan
Ye Yuan
HER2-positive breast cancer is an aggressive subtype that benefits from targeted therapies. According to the Chinese Society of Clinical Oncology (CSCO) gu